Remdesivir
Trial and error: How scientists studied drugs touted to treat COVID-19
Eyewitness News looks back on one of the drugs that was famously touted - even by people in influence - as part of a treatment regimen for COVID-19.
-
WHO advises against remdesivir for coronavirus treatment
The United States, the European Union and other countries have granted temporary approval for the use of remdesivir after initial research showed it may shorten recovery time in some coronavirus patients.
-
SA expert: More drug therapies need to be probed to treat COVID-19
Interim results from the WHO's Solidarity Therapeutics Trial show four drugs in a multinational study have little or no effect on 28-day mortality or the in-hospital clinical outcomes of severely ill, hospitalised COVID-19 patients.
-
Trump hospitalised for COVID-19 treatment, campaign grounded
Press Secretary Kayleigh McEnany said Trump was receiving the anti-viral drug remdesivir following consultation with specialists. The president was 'not requiring any supplemental oxygen,' she said in a statement late Friday.
-
WHO halts hydroxychloroquine, HIV drugs in COVID-19 trials
The setback came as the WHO also reported more than 200,000 new cases globally of the disease for the first time in a single day.
-
Gilead targets two million remdesivir courses by year-end
The company also said it planned to start trials of an easier-to-use inhaled version of the antiviral drug, currently administered only intravenously, by August.
-
India approves emergency use of remdesivir to treat COVID-19 patients
Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal clinical trials and is at the forefront of the battle against COVID-19.
-
WHO closely monitors Remdesivir as possible COVID-19 treatment drug
The drug forms part of the World Health Organisation’s (WHO) solidarity trial, an international clinical trial to help find an effective treatment for the virus.
-
EU regulator promises speedy review of potential COVID-19 drug remdesivir
The announcement comes two weeks after the EMA head told the European Parliament it may give an initial green light for sale of remdesivir as a COVID-19 treatment.
-
WHO sees 'potentially positive data' on COVID-19 treatments
More than 100 potential COVID-19 vaccines are being developed, including several in clinical trials. The WHO said in April a vaccine would take at least 12 months.
-
US says remdesivir shows 'clear-cut' effect in treating coronavirus
The finding represents the first time any medication has been shown to improve outcomes against the COVID-19 illness, which has claimed more than 220,000 lives globally and ground the world economy to a halt.
